Relation of acanthosis nigricans to hyperinsulinemia and insulin sensitivity in overweight African American and white children

被引:76
作者
Nguyen, TT
Keil, MF
Russell, DL
Pathomvanich, A
Uwaifo, GI
Sebring, NG
Reynolds, JC
Yanovski, JA
机构
[1] NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA
[2] NIH, Dept Nutr, Warren Grant Magnuson Clin Ctr, Bethesda, MD 20892 USA
[3] NIH, Dept Nucl Med, Warren Grant Magnuson Clin Ctr, Bethesda, MD USA
基金
美国国家卫生研究院;
关键词
D O I
10.1067/mpd.2001.112657
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objectives: Acanthosis nigricans (AN) has been proposed as a reliable marker of hyperinsulinemia but its utility for predicting hyperinsulinism has not been systematically evaluated in overweight children. We examined the relationship of AN to hyperinsulinemia and body adiposity. Study design: One hundred thirty-nine children underwent physical examination for AN, body composition studies, an oral glucose tolerance test, and a hyperglycemic clamp. Results: Thirty-five children (25%) had AN. AN was more prevalent in African Americans (50.1%) than in white subjects (8.2%, P < .001). Independent of race, children with AN had greater body weight and body fat mass (P < .001); greater basal and glucose-stimulated insulin levels during oral glucose tolerance test (P < .001); greater first-phase, second-phase, and steady-state insulin levels (P < .001); and lower insulin sensitivity (P < .001) during the hyperglycemic clamp. After adjusting for body fat mass and age. none of these differences remained significant. When categorized by fasting insulin, 35% with fasting insulin levels >20 muU/mL and 50% with fasting insulin levels >15 muU/mL did not have AN. Eighty-eight percent of children with fasting insulin levels greater than or equal to 15 muU/mL had a body mass index SE score greater than or equal to3.0. Conclusions: AN is not a reliable marker for hyperinsulinemia in over-weight children. Children with a race-, sex-, and age-specific body mass index SD scores greater than or equal to3.0 should be screened for hyperinsulinemia, whether or not they have AN.
引用
收藏
页码:474 / 480
页数:7
相关论文
共 27 条
[1]   MUTATIONS IN THE INSULIN-RECEPTOR GENE IN PATIENTS WITH GENETIC SYNDROMES OF INSULIN RESISTANCE AND ACANTHOSIS NIGRICANS [J].
ACCILI, D ;
BARBETTI, F ;
CAMA, A ;
KADOWAKI, H ;
KADOWAKI, T ;
IMANO, E ;
LEVYTOLEDANO, R ;
TAYLOR, SI .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1992, 98 (06) :S77-S81
[2]   Insulin secretion and sensitivity in black versus white prepubertal healthy children [J].
Arslanian, S ;
Suprasongsin, C ;
Janosky, JE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (06) :1923-1927
[3]   Acanthosis Nigricans as an early clinical proxy marker of increased risk of type II diabetes [J].
Bent, KN ;
Shuster, GF ;
Hurley, JS ;
Frye, D ;
Loflin, P ;
Brubaker, C .
PUBLIC HEALTH NURSING, 1998, 15 (06) :415-421
[4]   CHARACTERIZATION OF MONOCLONAL-ANTIBODIES TO THE IGF-I RECEPTOR THAT INHIBIT IGF-I BINDING TO HUMAN-CELLS [J].
FLIER, JS ;
MOSES, AC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 127 (03) :929-936
[5]  
Frisancho AR., 1990, Anthropometric standards for the measurement of growth and nutritional status
[6]  
Gruelich WW, 1959, RADIOGRAPHIC ATLAS S
[7]  
Hollingshead A. B., 1975, Yale Journal of Sociology
[8]   PREVALENCE AND SIGNIFICANCE OF ACANTHOSIS NIGRICANS IN AN ADULT OBESE POPULATION [J].
HUD, JA ;
COHEN, JB ;
WAGNER, JM ;
CRUZ, PD .
ARCHIVES OF DERMATOLOGY, 1992, 128 (07) :941-944
[9]   TRIAL OF INSULIN-LIKE GROWTH FACTOR-I THERAPY FOR PATIENTS WITH EXTREME INSULIN RESISTANCE SYNDROMES [J].
KUZUYA, H ;
MATSUURA, N ;
SAKAMOTO, M ;
MAKINO, H ;
SAKAMOTO, Y ;
KADOWAKI, T ;
SUZUKI, Y ;
KOBAYASHI, M ;
AKAZAWA, Y ;
NOMURA, M ;
YOSHIMASA, Y ;
KASUGA, M ;
GOJI, K ;
NAGATAKI, S ;
OYASU, H ;
IMURA, H .
DIABETES, 1993, 42 (05) :696-705
[10]  
Lohman TG., 1988, Anthropometric standardization reference manual, DOI DOI 10.2471/BLT.07.043497